Hit Enter to search or Esc to close
0
Erlotinib hydrochloride

Erlotinib hydrochloride

CAS NO.:183319-69-9
MF: C22H24ClN3O4
EINECS NO.:620-491-0
API069
Quantity
Send Inquiry
add to cart

Product Name
Erlotinib hydrochloride
Appearance
White or off-white powder
Specification
 99%
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Time
24 months

Erlotinib hydrochloride is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers.

Erlotinib hydrochloride is indicated for:
1.The treatment of metastatic non-small cell lung cancer (NSCLC) with tumors
showing epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations Label.
2.In combination with first-line treatment for patients diagnosed with locally advanced, unresectable or metastatic pancreatic cancer Label.